Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study.
Identifieur interne : 000F54 ( Main/Exploration ); précédent : 000F53; suivant : 000F55Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study.
Auteurs : Mario Ulises Pérez-Zepeda [Mexique] ; Eduardo Cárdenas-Cárdenas [Mexique] ; Matteo Cesari [France] ; Ana Patricia Navarrete-Reyes [Mexique] ; Luis Miguel Gutiérrez-Robledo [Mexique]Source :
- Journal of cancer survivorship : research and practice [ 1932-2267 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- psychologie : Tumeurs.
- Femelle, Humains, Mexique, Mâle, Personne âgée fragile, Prévalence, Sujet âgé, Survivants, Vieillissement, État de santé, Études cas-témoins, Études de cohortes.
English descriptors
- KwdEn :
- MESH :
- psychology : Neoplasms.
- Aged, Aging, Case-Control Studies, Cohort Studies, Female, Frail Elderly, Health Status, Humans, Male, Mexico, Prevalence, Survivors.
Abstract
PURPOSE
Understanding how the convergence between chronic and complex diseases-such as cancer-and emerging conditions of older adults-such as frailty-takes place would help in halting the path that leads to disability in this age group. The objective of this manuscript is to describe the association between a past medical history of cancer and frailty in Mexican older adults.
METHODS
This is a nested in cohort case-control study of the Mexican Health and Aging Study. Frailty was categorized by developing a 55-item frailty index that was also used to define cases in two ways: incident frailty (incident >0.25 frailty index score) and worsening frailty (negative residuals from a regression between 2001 and 2012 frailty index scores). Exposition was defined as self-report of cancer between 2001 and 2012. Older adults with a cancer history were further divided into recently diagnosed (<10 years) and remotely diagnosed (>10 years from the initial diagnosis). Odds ratios were estimated by fitting a logistic regression adjusted for confounding variables.
RESULTS
Out of a total of 8022 older adults with a mean age of 70.6 years, the prevalence of a past medical history of cancer was 3.6 % (n = 288). Among these participants, 45.1 % had been diagnosed with cancer more than 10 years previously. A higher risk of incident frailty compared to controls [odds ratio (OR) 1.53 (95 % confidence interval (CI) 1.04-2.26, p = 0.03); adjusted model OR 1.74 (95 % CI 1.15-2.61, p = 0.008)] was found in the group with a recent cancer diagnosis. Also, an inverse association between a remote cancer diagnosis and worsening frailty was found [OR = 0.56 (95 % CI 0.39-0.8), p = 0.002; adjusted model OR 0.61 (95 % CI 0.38-0.99, p = 0.046)].
CONCLUSIONS
Cancer is associated with a higher frailty index, with a potential relevant role of the time that has elapsed since the cancer diagnosis.
IMPLICATIONS FOR CANCER SURVIVORS
Cancer survivors may be more likely to develop frailty or worsening of the health status at an older age. This relationship seems especially evident among individuals with a recent oncological diagnosis. Health professionals in charge of older adult care should be aware of this association in order to improve outcomes of older adults who survived cancer.
DOI: 10.1007/s11764-016-0519-6
PubMed: 26856729
PubMed Central: PMC4966647
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study.</title><author><name sortKey="Perez Zepeda, Mario Ulises" sort="Perez Zepeda, Mario Ulises" uniqKey="Perez Zepeda M" first="Mario Ulises" last="Pérez-Zepeda">Mario Ulises Pérez-Zepeda</name><affiliation wicri:level="1"><nlm:affiliation>Geriatric Epidemiology Research Department, Instituto Nacional de Geriatría, Periférico Sur 2767, colonia San Jerónimo Lídice, delegación Magdalena Contreras, México DF, México, CP 10200, Mexico. ulises.perez@salud.gob.mx.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Geriatric Epidemiology Research Department, Instituto Nacional de Geriatría, Periférico Sur 2767, colonia San Jerónimo Lídice, delegación Magdalena Contreras, México DF, México, CP 10200</wicri:regionArea><wicri:noRegion>CP 10200</wicri:noRegion></affiliation></author><author><name sortKey="Cardenas Cardenas, Eduardo" sort="Cardenas Cardenas, Eduardo" uniqKey="Cardenas Cardenas E" first="Eduardo" last="Cárdenas-Cárdenas">Eduardo Cárdenas-Cárdenas</name><affiliation wicri:level="1"><nlm:affiliation>Oncology Service, Hospital 20 de Noviembre, Instituto de Salud y Seguridad Social de los Trabajadores del Estado, Mexico City, Mexico.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Oncology Service, Hospital 20 de Noviembre, Instituto de Salud y Seguridad Social de los Trabajadores del Estado, Mexico City</wicri:regionArea><wicri:noRegion>Mexico City</wicri:noRegion></affiliation></author><author><name sortKey="Cesari, Matteo" sort="Cesari, Matteo" uniqKey="Cesari M" first="Matteo" last="Cesari">Matteo Cesari</name><affiliation wicri:level="3"><nlm:affiliation>Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse III Paul Sabatier, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse III Paul Sabatier, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Navarrete Reyes, Ana Patricia" sort="Navarrete Reyes, Ana Patricia" uniqKey="Navarrete Reyes A" first="Ana Patricia" last="Navarrete-Reyes">Ana Patricia Navarrete-Reyes</name><affiliation wicri:level="1"><nlm:affiliation>Geriatric Department, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Geriatric Department, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City</wicri:regionArea><wicri:noRegion>Mexico City</wicri:noRegion></affiliation></author><author><name sortKey="Gutierrez Robledo, Luis Miguel" sort="Gutierrez Robledo, Luis Miguel" uniqKey="Gutierrez Robledo L" first="Luis Miguel" last="Gutiérrez-Robledo">Luis Miguel Gutiérrez-Robledo</name><affiliation wicri:level="1"><nlm:affiliation>Principal Office at the Instituto Nacional de Geriatría, Mexico City, Mexico.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Principal Office at the Instituto Nacional de Geriatría, Mexico City</wicri:regionArea><wicri:noRegion>Mexico City</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26856729</idno><idno type="pmid">26856729</idno><idno type="doi">10.1007/s11764-016-0519-6</idno><idno type="pmc">PMC4966647</idno><idno type="wicri:Area/Main/Corpus">000E99</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000E99</idno><idno type="wicri:Area/Main/Curation">000E99</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000E99</idno><idno type="wicri:Area/Main/Exploration">000E99</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study.</title><author><name sortKey="Perez Zepeda, Mario Ulises" sort="Perez Zepeda, Mario Ulises" uniqKey="Perez Zepeda M" first="Mario Ulises" last="Pérez-Zepeda">Mario Ulises Pérez-Zepeda</name><affiliation wicri:level="1"><nlm:affiliation>Geriatric Epidemiology Research Department, Instituto Nacional de Geriatría, Periférico Sur 2767, colonia San Jerónimo Lídice, delegación Magdalena Contreras, México DF, México, CP 10200, Mexico. ulises.perez@salud.gob.mx.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Geriatric Epidemiology Research Department, Instituto Nacional de Geriatría, Periférico Sur 2767, colonia San Jerónimo Lídice, delegación Magdalena Contreras, México DF, México, CP 10200</wicri:regionArea><wicri:noRegion>CP 10200</wicri:noRegion></affiliation></author><author><name sortKey="Cardenas Cardenas, Eduardo" sort="Cardenas Cardenas, Eduardo" uniqKey="Cardenas Cardenas E" first="Eduardo" last="Cárdenas-Cárdenas">Eduardo Cárdenas-Cárdenas</name><affiliation wicri:level="1"><nlm:affiliation>Oncology Service, Hospital 20 de Noviembre, Instituto de Salud y Seguridad Social de los Trabajadores del Estado, Mexico City, Mexico.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Oncology Service, Hospital 20 de Noviembre, Instituto de Salud y Seguridad Social de los Trabajadores del Estado, Mexico City</wicri:regionArea><wicri:noRegion>Mexico City</wicri:noRegion></affiliation></author><author><name sortKey="Cesari, Matteo" sort="Cesari, Matteo" uniqKey="Cesari M" first="Matteo" last="Cesari">Matteo Cesari</name><affiliation wicri:level="3"><nlm:affiliation>Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Université de Toulouse III Paul Sabatier, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Toulouse III Paul Sabatier, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Navarrete Reyes, Ana Patricia" sort="Navarrete Reyes, Ana Patricia" uniqKey="Navarrete Reyes A" first="Ana Patricia" last="Navarrete-Reyes">Ana Patricia Navarrete-Reyes</name><affiliation wicri:level="1"><nlm:affiliation>Geriatric Department, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Geriatric Department, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City</wicri:regionArea><wicri:noRegion>Mexico City</wicri:noRegion></affiliation></author><author><name sortKey="Gutierrez Robledo, Luis Miguel" sort="Gutierrez Robledo, Luis Miguel" uniqKey="Gutierrez Robledo L" first="Luis Miguel" last="Gutiérrez-Robledo">Luis Miguel Gutiérrez-Robledo</name><affiliation wicri:level="1"><nlm:affiliation>Principal Office at the Instituto Nacional de Geriatría, Mexico City, Mexico.</nlm:affiliation><country xml:lang="fr">Mexique</country><wicri:regionArea>Principal Office at the Instituto Nacional de Geriatría, Mexico City</wicri:regionArea><wicri:noRegion>Mexico City</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of cancer survivorship : research and practice</title><idno type="eISSN">1932-2267</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Aging (MeSH)</term><term>Case-Control Studies (MeSH)</term><term>Cohort Studies (MeSH)</term><term>Female (MeSH)</term><term>Frail Elderly (MeSH)</term><term>Health Status (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Mexico (MeSH)</term><term>Neoplasms (psychology)</term><term>Prevalence (MeSH)</term><term>Survivors (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Mexique (MeSH)</term><term>Mâle (MeSH)</term><term>Personne âgée fragile (MeSH)</term><term>Prévalence (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Survivants (MeSH)</term><term>Tumeurs (psychologie)</term><term>Vieillissement (MeSH)</term><term>État de santé (MeSH)</term><term>Études cas-témoins (MeSH)</term><term>Études de cohortes (MeSH)</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aging</term><term>Case-Control Studies</term><term>Cohort Studies</term><term>Female</term><term>Frail Elderly</term><term>Health Status</term><term>Humans</term><term>Male</term><term>Mexico</term><term>Prevalence</term><term>Survivors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Femelle</term><term>Humains</term><term>Mexique</term><term>Mâle</term><term>Personne âgée fragile</term><term>Prévalence</term><term>Sujet âgé</term><term>Survivants</term><term>Vieillissement</term><term>État de santé</term><term>Études cas-témoins</term><term>Études de cohortes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b></p><p>Understanding how the convergence between chronic and complex diseases-such as cancer-and emerging conditions of older adults-such as frailty-takes place would help in halting the path that leads to disability in this age group. The objective of this manuscript is to describe the association between a past medical history of cancer and frailty in Mexican older adults.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>This is a nested in cohort case-control study of the Mexican Health and Aging Study. Frailty was categorized by developing a 55-item frailty index that was also used to define cases in two ways: incident frailty (incident >0.25 frailty index score) and worsening frailty (negative residuals from a regression between 2001 and 2012 frailty index scores). Exposition was defined as self-report of cancer between 2001 and 2012. Older adults with a cancer history were further divided into recently diagnosed (<10 years) and remotely diagnosed (>10 years from the initial diagnosis). Odds ratios were estimated by fitting a logistic regression adjusted for confounding variables.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Out of a total of 8022 older adults with a mean age of 70.6 years, the prevalence of a past medical history of cancer was 3.6 % (n = 288). Among these participants, 45.1 % had been diagnosed with cancer more than 10 years previously. A higher risk of incident frailty compared to controls [odds ratio (OR) 1.53 (95 % confidence interval (CI) 1.04-2.26, p = 0.03); adjusted model OR 1.74 (95 % CI 1.15-2.61, p = 0.008)] was found in the group with a recent cancer diagnosis. Also, an inverse association between a remote cancer diagnosis and worsening frailty was found [OR = 0.56 (95 % CI 0.39-0.8), p = 0.002; adjusted model OR 0.61 (95 % CI 0.38-0.99, p = 0.046)].</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Cancer is associated with a higher frailty index, with a potential relevant role of the time that has elapsed since the cancer diagnosis.</p></div><div type="abstract" xml:lang="en"><p><b>IMPLICATIONS FOR CANCER SURVIVORS</b></p><p>Cancer survivors may be more likely to develop frailty or worsening of the health status at an older age. This relationship seems especially evident among individuals with a recent oncological diagnosis. Health professionals in charge of older adult care should be aware of this association in order to improve outcomes of older adults who survived cancer.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26856729</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-2267</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>08</Month></PubDate></JournalIssue><Title>Journal of cancer survivorship : research and practice</Title><ISOAbbreviation>J Cancer Surviv</ISOAbbreviation></Journal><ArticleTitle>Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study.</ArticleTitle><Pagination><MedlinePgn>736-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11764-016-0519-6</ELocationID><Abstract><AbstractText Label="PURPOSE">Understanding how the convergence between chronic and complex diseases-such as cancer-and emerging conditions of older adults-such as frailty-takes place would help in halting the path that leads to disability in this age group. The objective of this manuscript is to describe the association between a past medical history of cancer and frailty in Mexican older adults.</AbstractText><AbstractText Label="METHODS">This is a nested in cohort case-control study of the Mexican Health and Aging Study. Frailty was categorized by developing a 55-item frailty index that was also used to define cases in two ways: incident frailty (incident >0.25 frailty index score) and worsening frailty (negative residuals from a regression between 2001 and 2012 frailty index scores). Exposition was defined as self-report of cancer between 2001 and 2012. Older adults with a cancer history were further divided into recently diagnosed (<10 years) and remotely diagnosed (>10 years from the initial diagnosis). Odds ratios were estimated by fitting a logistic regression adjusted for confounding variables.</AbstractText><AbstractText Label="RESULTS">Out of a total of 8022 older adults with a mean age of 70.6 years, the prevalence of a past medical history of cancer was 3.6 % (n = 288). Among these participants, 45.1 % had been diagnosed with cancer more than 10 years previously. A higher risk of incident frailty compared to controls [odds ratio (OR) 1.53 (95 % confidence interval (CI) 1.04-2.26, p = 0.03); adjusted model OR 1.74 (95 % CI 1.15-2.61, p = 0.008)] was found in the group with a recent cancer diagnosis. Also, an inverse association between a remote cancer diagnosis and worsening frailty was found [OR = 0.56 (95 % CI 0.39-0.8), p = 0.002; adjusted model OR 0.61 (95 % CI 0.38-0.99, p = 0.046)].</AbstractText><AbstractText Label="CONCLUSIONS">Cancer is associated with a higher frailty index, with a potential relevant role of the time that has elapsed since the cancer diagnosis.</AbstractText><AbstractText Label="IMPLICATIONS FOR CANCER SURVIVORS">Cancer survivors may be more likely to develop frailty or worsening of the health status at an older age. This relationship seems especially evident among individuals with a recent oncological diagnosis. Health professionals in charge of older adult care should be aware of this association in order to improve outcomes of older adults who survived cancer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pérez-Zepeda</LastName><ForeName>Mario Ulises</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Geriatric Epidemiology Research Department, Instituto Nacional de Geriatría, Periférico Sur 2767, colonia San Jerónimo Lídice, delegación Magdalena Contreras, México DF, México, CP 10200, Mexico. ulises.perez@salud.gob.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cárdenas-Cárdenas</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Oncology Service, Hospital 20 de Noviembre, Instituto de Salud y Seguridad Social de los Trabajadores del Estado, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cesari</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université de Toulouse III Paul Sabatier, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarrete-Reyes</LastName><ForeName>Ana Patricia</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Geriatric Department, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutiérrez-Robledo</LastName><ForeName>Luis Miguel</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Principal Office at the Instituto Nacional de Geriatría, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG018016</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cancer Surviv</MedlineTA><NlmUniqueID>101307557</NlmUniqueID><ISSNLinking>1932-2259</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016330" MajorTopicYN="N">Frail Elderly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N">Mexico</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic disease</Keyword><Keyword MajorTopicYN="N">Disability</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Oncogeriatrics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>01</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26856729</ArticleId><ArticleId IdType="doi">10.1007/s11764-016-0519-6</ArticleId><ArticleId IdType="pii">10.1007/s11764-016-0519-6</ArticleId><ArticleId IdType="pmc">PMC4966647</ArticleId><ArticleId IdType="mid">NIHMS802290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Am Med Dir Assoc. 2014 Jul;15(7):528-30</Citation><ArticleIdList><ArticleId IdType="pubmed">24835855</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Hypotheses. 2006;67(2):212-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16546325</ArticleId></ArticleIdList></Reference><Reference><Citation>J Aging Health. 2011 Oct;23(7):1050-74</Citation><ArticleIdList><ArticleId IdType="pubmed">21948770</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Intern Med. 2011 Dec;26(12):1403-10</Citation><ArticleIdList><ArticleId IdType="pubmed">21785923</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Cancer Inst. 2009 Sep 2;101(17):1206-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19638506</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2009 Jul 10;27(20):3338-45</Citation><ArticleIdList><ArticleId IdType="pubmed">19380442</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Physiol. 2013;75:685-705</Citation><ArticleIdList><ArticleId IdType="pubmed">23140366</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Clin North Am. 2006 Sep;90(5):837-47</Citation><ArticleIdList><ArticleId IdType="pubmed">16962845</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2015 Jan 27;:null</Citation><ArticleIdList><ArticleId IdType="pubmed">25626437</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 2014 Jan;43(1):10-2</Citation><ArticleIdList><ArticleId IdType="pubmed">24132852</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63</Citation><ArticleIdList><ArticleId IdType="pubmed">15031310</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Geriatr. 2008 Sep 30;8:24</Citation><ArticleIdList><ArticleId IdType="pubmed">18826625</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1999 Jan 16;353(9148):205-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9923878</ArticleId></ArticleIdList></Reference><Reference><Citation>Endocr Relat Cancer. 2004 Sep;11(3):523-35</Citation><ArticleIdList><ArticleId IdType="pubmed">15369452</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2007 Jan;12(1):20-37</Citation><ArticleIdList><ArticleId IdType="pubmed">17227898</ArticleId></ArticleIdList></Reference><Reference><Citation>Salud Publica Mex. 2007;49 Suppl 4:S436-47</Citation><ArticleIdList><ArticleId IdType="pubmed">17724516</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol B Psychol Sci Soc Sci. 2002 Mar;57(2):S117-25</Citation><ArticleIdList><ArticleId IdType="pubmed">11867672</ArticleId></ArticleIdList></Reference><Reference><Citation>J Natl Compr Canc Netw. 2013 May;11(5 Suppl):640-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23704233</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2002 Nov 11;162(20):2333-41</Citation><ArticleIdList><ArticleId IdType="pubmed">12418947</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2009 Jul;122(7):605-13</Citation><ArticleIdList><ArticleId IdType="pubmed">19559159</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Med Dir Assoc. 2011 Feb;12(2):153-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21266292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):738-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17634321</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fam Med. 2004 Jan-Feb;2(1):61-70</Citation><ArticleIdList><ArticleId IdType="pubmed">15053285</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2013 Apr;21(4):941-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23052915</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Oncol. 2012 Sep 10;30(26):3271-6</Citation><ArticleIdList><ArticleId IdType="pubmed">22649143</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Oncol Hematol. 2000 Sep;35(3):147-54</Citation><ArticleIdList><ArticleId IdType="pubmed">10960797</ArticleId></ArticleIdList></Reference><Reference><Citation>Age Ageing. 2004 Sep;33(5):429-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15315912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer. 2002 May 15;94(10):2766-92</Citation><ArticleIdList><ArticleId IdType="pubmed">12173348</ArticleId></ArticleIdList></Reference><Reference><Citation>Support Care Cancer. 2014 Jul;22(7):1727-34</Citation><ArticleIdList><ArticleId IdType="pubmed">24584682</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Mexique</li></country><region><li>Midi-Pyrénées</li><li>Occitanie (région administrative)</li></region><settlement><li>Toulouse</li></settlement></list><tree><country name="Mexique"><noRegion><name sortKey="Perez Zepeda, Mario Ulises" sort="Perez Zepeda, Mario Ulises" uniqKey="Perez Zepeda M" first="Mario Ulises" last="Pérez-Zepeda">Mario Ulises Pérez-Zepeda</name></noRegion><name sortKey="Cardenas Cardenas, Eduardo" sort="Cardenas Cardenas, Eduardo" uniqKey="Cardenas Cardenas E" first="Eduardo" last="Cárdenas-Cárdenas">Eduardo Cárdenas-Cárdenas</name><name sortKey="Gutierrez Robledo, Luis Miguel" sort="Gutierrez Robledo, Luis Miguel" uniqKey="Gutierrez Robledo L" first="Luis Miguel" last="Gutiérrez-Robledo">Luis Miguel Gutiérrez-Robledo</name><name sortKey="Navarrete Reyes, Ana Patricia" sort="Navarrete Reyes, Ana Patricia" uniqKey="Navarrete Reyes A" first="Ana Patricia" last="Navarrete-Reyes">Ana Patricia Navarrete-Reyes</name></country><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Cesari, Matteo" sort="Cesari, Matteo" uniqKey="Cesari M" first="Matteo" last="Cesari">Matteo Cesari</name></region><name sortKey="Cesari, Matteo" sort="Cesari, Matteo" uniqKey="Cesari M" first="Matteo" last="Cesari">Matteo Cesari</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/AutomedicationFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F54 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F54 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= AutomedicationFrancoV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26856729
|texte= Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26856729" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AutomedicationFrancoV1
| This area was generated with Dilib version V0.6.38. |  |